An Iowa-based band formed by chance backed new wave icon Lene Lovich on tour with Devo and The B-52s, proving chemistry beats ...
Zacks Investment Research on MSN
United Fire Group, Inc (UFCS) hit a 52 week high, can the run continue?
Shares of United Fire Group (UFCS) have been strong performers lately, with the stock up 2.2% over the past month. The stock hit a new 52-week high of $37.91 in the previous session. United Fire has ...
At the time of writing, the ASX 200 stock is up 3.5% to $5.23. Get Started Investing You can do it. Learn about investing ...
The Canadian Press on MSN
B.C. Union that represents 67,500 health workers votes 54.2 per cent for 4 year deal
BURNABY - The bargaining group that represents 67,500 health workers in British Columbia has voted 54.2 per cent in favour of ...
Zacks Investment Research on MSN
Huron Consulting Group Inc. (HURN) hit a 52-week high, can the run continue?
Shares of Huron Consulting (HURN) have been strong performers lately, with the stock up 10.6% over the past month. The stock hit a new 52-week high of $181.5 in the previous session. Huron Consulting ...
Triton Partners sold assets for more than it had told original backers they would be worth after putting them into a continuation fund ...
BusinessWorld on MSN
Federal Land divests 52% stake in Crown Central
FEDERAL LAND, INC. (FLI), the property arm of GT Capital Holdings, Inc., and its subsidiary Horizon Land Property Development Corp. have sold their combined 52% stake in Crown Central Properties Corp.
A Downtown Los Angeles office tower traded for $210 million, or $200 per square foot — and a Beverly Hills office campus for ...
Stingray Group Inc. (TSX: RAY.A; RAY.B) (“Stingray” or the “Company”), an industry leader in music and video content distribution, business services, and advertising ...
Share Market Highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 22 December 2025 ...
Not just anyone can mentor at-risk youth. It takes patience, determination and a willingness to commit to a child’s ...
Findings from the phase 1/2 BRUIN study (NCT03740529) show that pirtobrutinib (Jaypirca), a Bruton tyrosine kinase inhibitor (BTKi), monotherapy offers promising clinical efficacy and a favorable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results